Form D · Pharmaceuticals
VST BIO Corp
San Diego, CA · CIK 0002093250
Offering snapshot reported Apr 24, 2026 · SEC filing
- Reported sold
- $31.9M Offering amount: $31.9M
- Investors reported
- 1 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Nov 5, 2025 As reported in this filing
Fundraising history
Reported soldDates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.
What changed?
Latest filing versus its linked predecessor, where available.
- Reported sold$28,888,146 → $31,888,146
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Apr 24, 2026 | Amendment | $31,888,146 | $3,000,000vs Nov 18, 2025 | 1 | SEC filing |
| Nov 18, 2025 | Initial | $28,888,146 | No comparison | 1 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-564343
Includes amounts paid both in cash and pursuant to automatic conversion of indebtedness.
Source: Form D, filed Apr 24, 2026. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No matching detailed fund disclosure was found in the latest imported ADV filings. This does not establish that the issuer has no adviser.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| David Cheresh | Director |
| Rebecque Laba | Executive |
| William Sessa | Director |
| Chris Somerville | Director |
| J. Anthony Ware | Director |
| Krisztina Zsebo | Director, Executive |
Issuer details
Industry: Pharmaceuticals (See others in industry)
Address:San Diego, CA, 92130
Phone: (858) 663-8641